Visilizumab
Product Specifications
CAS Number
219716-33-3
Target
Others|||Apoptosis
Related Pathways
Others|||Apoptosis
Purity
0.994
Bioactivity
Visilizumab is a humanized IgG2 monoclonal antibody engineered to target the CD3 antigen on T-cells while exhibiting low Fc receptor binding activity to minimize activation-induced cytotoxicity. this unique design potentially suppresses the body's immune response through the modulation of T-cell function, and Visilizumab can be used in studies about the treatment of ulcerative colitis and Crohn's disease.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1285591-01 0.02 mg (E-Coli)
Recombinant Nitrosospira multiformis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
Ask
View Details MBS1285591-02 0.02 mg (Yeast)
Recombinant Nitrosospira multiformis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
Ask
View Details